Results 281 to 290 of about 885,175 (334)

Advanced extracellular vesicle immunotherapy

FlexMat, EarlyView.
A diagrammatic depiction of the therapeutic applicability of extracellular vesicles (EVs) in immunotherapy. This review explores the dual roles of tumor‐derived and immune cell‐derived EVs in cancer immunotherapy, discusses recent progress in EV engineering that improve their clinical utility, and evaluates their potential to augment existing ...
Jingjing Zhang, Yunfei Mu, Xianyue Ji, Xiaoting Jiang, Ruiheng Wang, Xianguang Ding, Lianhui Wang   +6 more
wiley   +1 more source

Tumor-Infiltrating Lymphocyte Therapy for the Treatment of Metastatic Melanoma. [PDF]

Am J Clin Dermatol
Tsai KK, Komanduri KV.
europepmc   +1 more source

Genomic and Immune Correlates of EZH2 Expression and Activity in Olfactory Neuroblastoma

Head &Neck, EarlyView.
ABSTRACT Purpose Olfactory neuroblastoma (ONB) is a rare sinonasal malignancy with limited therapeutic options in the recurrent/metastatic setting; little is known regarding its responsiveness to immunotherapy. Inhibition of enhancer of zeste homolog 2 (EZH2) has been shown to improve T‐cell‐mediated killing and susceptibility to immune checkpoint ...
Elisabetta Xue, Tolulope Adeyelu, Harris Krause, Andrew Elliott, Ranee Mehra, Heloisa Soares, Emil Lou, Ari Vanderwalde, David Spetzler, Dara Bracken‐Clarke, Nyall R. London Jr., James L. Gulley, Charalampos S. Floudas   +12 more
wiley   +1 more source

Investigating Chronic Toxicity, Diet, Patient-Reported Outcomes and the Microbiome in Immunotherapy-Treated Metastatic Melanoma Survivors: A New Frontier. [PDF]

Nutrients
Robert M, Saha S, Dizman N, Rohlfs M, Sirmans E, Simon J, Amaria RN, Glitza Oliva IC, Tawbi HA, Davies MA, Ikeguchi A, Basen-Engquist K, Schadler K, Roth ME, Song W, Zhang X, Ajami NJ, Cohen L, Wargo JA, Peterson CB, McQuade JL, Daniel CR.   +21 more
europepmc   +1 more source

Image 2_Circulating memory B-cell receptor repertoire analysis identifies novel candidate antibodies against metastatic melanoma in immunotherapy-responsive patients.jpeg

Fabio Nicolini (15833024), Anna Gaimari (22402210), Lucia Mazzotti (12880148), Anna De Lucia (22402213), Miriana Ghirelli (22402216), Valentina Ancarani (2681653), Patricia Borges de Souza (22402219), Matteo Zurlo (7372766), Luca Gazzola (22402222), Chiara Magnoni (22402225), Simona Capobianco (22402228), Davide Angeli (6627308), Sara Bravaccini (9232115), Claudio Cerchione (9723023), Massimo Guidoboni (7478195), Luisa Lanfrancone (7911848), Federica Marocchi (22402231), Roberta Maltoni (11125), Maria Maddalena Tumedei (9632993), Francesco Limarzi (9632996), Luigi Pasini (3418382), Laura Ridolfi (7478165), Massimiliano Mazza (6035009)   +22 more
openalex   +1 more source

Metastatic melanoma

, 2009
openaire   +1 more source

Nivolumab-Induced Hemophagocytic Lymphohistiocytosis (HLH) in a Patient With Metastatic Melanoma: A Case Report and Literature Review. [PDF]

Cureus
Virdi RK, Hussain U, Bitran J.
europepmc   +1 more source

Gene-expression signature predicts autoimmune toxicity in metastatic melanoma. [PDF]

J Immunother Cancer
Mallardo D, Fordellone M, Bailey M, White A, Simeone E, Festino L, Vanella V, Trojaniello C, Vitale MG, Ottaviano M, Capone M, Costa C, Ingenito M, Sparano F, Facchini BA, Cavalcanti E, De Filippi R, Caracò C, Cesano A, Warren S, Chiodini P, Budillon A, Ascierto PA.   +22 more
europepmc   +1 more source